CHINA CINDA (01359): Wang Kunhui nominated as non-executive director
China Sinopharm International Corporation (01359) announced that the board of directors has nominated Mr. Wang Kunhui (Mr. Wang) to serve as a non-executive director of the company. Mr. Wang will assume his duties after approval at the shareholders' meeting and confirmation of his qualifications by the China Banking and Insurance Regulatory Commission, with a term of three years.
CHINA CINDA (01359) announced that the Board of Directors has nominated Mr. Wang Kunhui (Mr. Wang) to serve as a non-executive director of the company. Mr. Wang will assume office after being approved by the company's shareholders' meeting and upon the qualification approval from the China Banking and Insurance Regulatory Commission, for a term of three years.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
